These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 26565779)

  • 21. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alkaloids as potential anti-tubercular agents.
    Kishore N; Mishra BB; Tripathi V; Tiwari VK
    Fitoterapia; 2009 Apr; 80(3):149-63. PubMed ID: 19344681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential of marine natural Products: Recent Advances in the discovery of Anti-Tuberculosis agents.
    Peng X; Zeng Z; Hassan S; Xue Y
    Bioorg Chem; 2024 Oct; 151():107699. PubMed ID: 39128242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereochemistry at the forefront in the design and discovery of novel anti-tuberculosis agents.
    Huang Q; He R; Kozikowski AP
    Curr Top Med Chem; 2011; 11(7):810-8. PubMed ID: 21291395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges and opportunities in developing novel drugs for TB.
    Kaneko T; Cooper C; Mdluli K
    Future Med Chem; 2011 Sep; 3(11):1373-400. PubMed ID: 21879843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M; Ma S
    ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Advances in the Discovery and Development of Marine Natural Products with Cardiovascular Pharmacological Effects.
    Zhou JB; Luo R; Zheng YL; Pang JY
    Mini Rev Med Chem; 2018; 18(6):527-550. PubMed ID: 28969542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural products, small molecules, and genetics in tuberculosis drug development.
    Gutierrez-Lugo MT; Bewley CA
    J Med Chem; 2008 May; 51(9):2606-12. PubMed ID: 18393405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico comparison of antimycobacterial natural products with known antituberculosis drugs.
    Espinoza-Moraga M; Njuguna NM; Mugumbate G; Caballero J; Chibale K
    J Chem Inf Model; 2013 Mar; 53(3):649-60. PubMed ID: 23410241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
    Ganihigama DU; Sureram S; Sangher S; Hongmanee P; Aree T; Mahidol C; Ruchirawat S; Kittakoop P
    Eur J Med Chem; 2015 Jan; 89():1-12. PubMed ID: 25462220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium tuberculosis-Secreted Tyrosine Phosphatases as Targets Against Tuberculosis: Exploring Natural Sources in Searching for New Drugs.
    Mascarello A; Chiaradia-Delatorre LD; Mori M; Terenzi H; Botta B
    Curr Pharm Des; 2016; 22(12):1561-9. PubMed ID: 26759082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of new antituberculosis drugs from natural products.
    Igarashi M
    Biosci Biotechnol Biochem; 2017 Jan; 81(1):32-37. PubMed ID: 27885931
    [No Abstract]   [Full Text] [Related]  

  • 33. The War against Tuberculosis: A Review of Natural Compounds and Their Derivatives.
    Maiolini M; Gause S; Taylor J; Steakin T; Shipp G; Lamichhane P; Deshmukh B; Shinde V; Bishayee A; Deshmukh RR
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32630150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural products and their analogues acting against Mycobacterium tuberculosis: A recent update.
    Kumar G; C A
    Drug Dev Res; 2023 Aug; 84(5):779-804. PubMed ID: 37086027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural product growth inhibitors of Mycobacterium tuberculosis.
    Copp BR; Pearce AN
    Nat Prod Rep; 2007 Apr; 24(2):278-97. PubMed ID: 17389998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico approaches and chemical space of anti-P-type ATPase compounds for discovering new antituberculous drugs.
    Santos P; López-Vallejo F; Soto CY
    Chem Biol Drug Des; 2017 Aug; 90(2):175-187. PubMed ID: 28111912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets.
    Hudson SA; McLean KJ; Munro AW; Abell C
    Biochem Soc Trans; 2012 Jun; 40(3):573-9. PubMed ID: 22616869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.
    Herrmann J; Lukežič T; Kling A; Baumann S; Hüttel S; Petković H; Müller R
    Curr Top Microbiol Immunol; 2016; 398():339-363. PubMed ID: 27738913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead.
    Grotz E; Tateosian N; Amiano N; Cagel M; Bernabeu E; Chiappetta DA; Moretton MA
    Pharm Res; 2018 Sep; 35(11):213. PubMed ID: 30238168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Mycobacterium tuberculosis whole cell screening hits as potential antituberculosis agents.
    Cooper CB
    J Med Chem; 2013 Oct; 56(20):7755-60. PubMed ID: 23927683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.